Navigation Links
AtheroNova Adds New Medical Advisor
Date:4/11/2013

IRVINE, Calif., April 11, 2013 /PRNewswire/ -- AtheroNova Inc. (OTCBB:AHRO), a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announced that Stephen Nicholls , M.B.B.S., PhD., Heart Disease Theme leader at the South Australia Health and Medical Research Institute (SAHMRI), has been appointed as chair of the newly renamed Clinical Advisory Board, replacing the recently retired Dr. Giorgio Zadini , one of the co-founders of AtheroNova.  Dr. Nicholls will also be a Co-Principal Investigator in the Company's upcoming clinical trials.

"As we continue to make positive strides, this is a key step in our evolution from a pre-clinical to a clinical stage pharmaceutical company as we move toward entry into Phase 1 in the near future.  Dr. Nicholls brings a wealth of experience in the imaging and analysis of cardiovascular plaque as we target the treatment of both serum cholesterol as well as atherosclerosis with AHRO-001," stated Thomas W. Gardner , CEO of AtheroNova. "Dr. Nicholls' experience with clinical developments during his time at the Cleveland Clinic as well as his new role as the key theme leader in one of the premier research organizations in Australia is essential in leading our Clinical Advisory Board.  We would like to thank Dr. Zadini for all of his tremendous efforts and accomplishments as the key medical advisor of the Company during the development stage and wish him well."

"Steve is one of the world's most respected authorities in the imaging of atherosclerosis," commented Mark Wedel , M.D., Chief Medical Officer of AtheroNova.  "We are profoundly fortunate and appreciative to benefit from his leadership and expertise as we move forward.
'/>"/>

SOURCE AtheroNova Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. AtheroNova Receives Notice of Issuance of Its U.S. Patent 8,304,383
2. AtheroNova Names New Director
3. AtheroNova to Present at Rodman & Renshaw 14th Annual Healthcare Conference in New York City
4. AtheroNova Releases 2011 Financial Results
5. AtheroNova Achieves Milestone in Initiating First Shipment of AHRO-001
6. AtheroNova Announces a New Board Member
7. AtheroNova and Maxwell Biotech Group Ratify Agreement to Develop New Atherosclerosis Drug
8. AtheroNova Inc. Preclinical Study Demonstrates 95% Reduction in Arterial Plaque Formation
9. Nanotherapeutics Awarded Defense Department Contract for Advanced Development and Manufacturing of Medical Countermeasures
10. “Scientific And Medical Research On The Successful Treatment Of Type 1 + 2 Diabetes With Alkaline Reduced Water” is Reviewed in Today’s Bawell Water Ionizer Health Report
11. Dermatology Associates Medical Group in Beverly Hills Announces Safe, Fast Anti-Aging Laser Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... ... ... been used in countless labs for decades. In the past, people had to go ... this was a daunting and tiring process looking at endless data tables and charts. ... the complex catalog structure. , Now thanks to FireflySci, scientists are throwing away those old ...
(Date:7/2/2015)... -- Amici Procurement Migrates to the Cloud ... has chosen Microsoft Cloud Solution Provider iomart ...      (Logo: http://photos.prnewswire.com/prnh/20121126/579634) , ... the bio-tech sector with a unique procurement service, helping ... help them obtain best value. Its IT platform hosts ...
(Date:7/1/2015)... ... 01, 2015 , ... It is now possible to separate two common disorders: ... computed tomography (SPECT) according to researchers from Amen Clinics, UCLA, Thomas Jefferson University, ... and is believed to be the largest brain imaging study ever, will be published ...
(Date:7/1/2015)... ... July 01, 2015 , ... The next-generation sequencing (NGS) clinical market is ... the molecular diagnostics industry. BCC Research reveals in its new report that the market ... costs, and a growing need for better diagnostics as part of a molecular diagnostics ...
Breaking Biology Technology:New Cuvette E-Commerce Website Launched by FireflySci 2Biotech Procurement Company Moves to Office 365 with iomart 2Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 2Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 3Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 4NGS-Based Diagnostics, the ‘Must-Have Platform’, Sends Market Segment CAGRs Soaring According to BCC Research 2NGS-Based Diagnostics, the ‘Must-Have Platform’, Sends Market Segment CAGRs Soaring According to BCC Research 3
... event was announced today by We Work for Health of ... for Health of Maryland is a coalition of leaders in ... will discuss the impact of the bioscience community on Maryland ... medical innovation in Maryland.President Obama has called for a new ...
... announces the following Webcast: , , What: ... Conference Call, When: ... Where: http://www.transgenomic.com/events.asp?id=6 , How: ... address above., ...
... March 18 BioMarin Pharmaceutical Inc. (Nasdaq: ... trial authorization (CTA) for BMN 110 or N-acetylgalactosamine 6-sulfatase ... disorder Mucopolysaccharidosis Type IVA (MPS IVA), or Morquio A ... and Healthcare Products Regulatory Agency (MHRA). BioMarin expects to ...
Cached Biology Technology:Maryland Business, Academic and Biopharma Groups Underscore Commitment to Medical Innovation, Finding Cures and Supporting the Economy 2Reminder - Webcast Alert: Transgenomic Inc. Announces Fourth Quarter 2008 Earnings Release Conference Call Webcast 2BioMarin's Clinical Trial Application for GALNS for Morquio A Syndrome Accepted by the MHRA 2BioMarin's Clinical Trial Application for GALNS for Morquio A Syndrome Accepted by the MHRA 3BioMarin's Clinical Trial Application for GALNS for Morquio A Syndrome Accepted by the MHRA 4
(Date:6/16/2015)... 16, 2015 /CNW Telbec/ - handyem Inc. and ... the incorporation of handyem,s HPC-150 portable flow cytometer ... Mo-POD™. This unprecedented model of mobile laboratory platform ... the Pennsylvania Convention Center, ... th to 18 th 2015.  By ...
(Date:6/15/2015)... NEW YORK , June 15, 2015 ... released today from Telstra reveals the majority of US consumers ... recognise them via biometrics, such as fingerprint and voiceprint, instead ... usernames. According to Telstra,s " Mobile Identity   ... " report, with smartphones now the primary channel ...
(Date:6/9/2015)...   MedNet Solutions , an innovative SaaS-based eClinical ... research, will be providing demonstrations of its ... Drug Information Association (DIA) Annual Meeting in ... will include previews of many exciting new enhancements that ... iMedNet 2015 Feature 1 Release. ...
Breaking Biology News(10 mins):handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 2handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 3One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 2One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 3One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 4MedNet To Provide Sneak Peeks Of Its iMedNet "2015 Feature 1 Release" At The DIA Annual Meeting 2MedNet To Provide Sneak Peeks Of Its iMedNet "2015 Feature 1 Release" At The DIA Annual Meeting 3
... CA Newly launched nerve cells in a growing embryo must ... they use to navigate have yet to surface. In a study ... the Salk Institute for Biological Studies have recovered a key signal ... the spinal cord and must find their way down the length ...
... in the upcoming Acoustical Society of America (ASA) meeting ... World Wide pressroom even if they cannot attend in ... language papers selected from among the 600 talks and ... physics, sound engineering, marine biology, medicine, meteorology, and music. ...
... set up a new institute to focus funding, coordinate ... into cardiovascular disease, the cause of between 30 and ... The European Vascular Biology Institute (EVBI) is being presented ... 2007 with a specific brief to convert research into ...
Cached Biology News:Salk scientists identify key nerve navigation pathway 2Salk scientists identify key nerve navigation pathway 3Acoustics World Wide press room now open 2Acoustics World Wide press room now open 3Acoustics World Wide press room now open 4Proposal to step up cardiovascular disease research 2
...
...
For mRNA Differential Display with three one-base anchored oligo-dT primers and rationally designed arbitrary 13mers. These kits feature the latest generation of isotopic mRNA Differential Display t...
Request Info...
Biology Products: